glenmark | Udaipur Kiran

Glenmark Pharmaceuticals executes agreement to transfer its API business

10 Oct 2018 1:33 PM by Bhupendra Singh Chundawat

Glenmark Pharmaceuticals has executed business purchase agreement for transfer of the company’s API business to its wholly owned subsidiary — Glenmark Life Sciences on October 9, 2018. The transaction is expected to be completed in the next 2-3 months. Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new … Read more

Glenmark Pharmaceutical launches biosimilar of Adalimumab in India

4 Jan 2018 1:46 PM by Bhupendra Singh Chundawat

Glenmark Pharmaceuticals has launched the biosimilar of Adalimumab under a licensing agreement with Cadila Healthcare, the Zydus group for the treatment of Plaque Psoriasis and Rheumatoid Arthritis. Developed by the researchers at the Zydus Research Centre, the biosimilar of Adalimumab was first launched by Zydus in 2014 and is manufactured at Zydus Biologics, the dedicated … Read more